skip to Main Content

News

Latest News, Announcements, and Press Releases

09Aug 13

Codexis Reports Second Quarter 2013 Results

— Conference call on August 15th at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 9, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the…
read more
05Aug 13

Codexis Reschedules Second Quarter 2013 Financial Results

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that the company has rescheduled the release of its second quarter financial results due to…
read more
14May 13

Codexis to Present at 2013 UBS Global Healthcare Conference

REDWOOD CITY, Calif.–(BUSINESS WIRE)–May. 14, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the…
read more
07May 13

Codexis Reports First Quarter 2013 Results

— Product gross margin increases to 38%; Product revenue up 34% from fourth quarter 2012 — — Conference call today at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–May. 7, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins with Codexis

Back To Top
Close search
Search